ClinicalTrials.Veeva

Menu

Acceptance-Based Treatment for Generalized Anxiety Disorder

U

University of Massachusetts, Worcester

Status and phase

Completed
Phase 1

Conditions

Generalized Anxiety Disorder
Anxiety Disorders

Treatments

Behavioral: Acceptance Based Behavioral Therapy

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00073632
R21MH063208 (U.S. NIH Grant/Contract)
DSIR AT-AS

Details and patient eligibility

About

This study will develop and implement an awareness- and acceptance-based for treatment of individuals with generalized anxiety disorder.

Full description

Participants in this study are recruited from intakes at the Center for Anxiety and Related Disorders at Boston University. Participants will be randomly assigned to receive either acceptance and mindfulness-based strategies plus cognitive behavioral therapy or no treatment for 16 weeks. The treatment will involve daily practice of mindfulness techniques to help draw attention to and accept various emotional states. Interviews, questionnaires, and depression and anxiety scales will be used to assess participants. Assessments will be conducted post-treatment and at 3- and 9-month follow-up visits.

Enrollment

50 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Generalized Anxiety Disorder (GAD)
  • Willing to maintain medication levels and refrain from any additional psychosocial treatment during the course of the study

Exclusion criteria

  • Bipolar disorder, psychotic disorder, or substance dependence

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems